Federico Zazzetti, MD

Janssen
Buenos Aires, Argentina

Global Medical Affairs Lead, Rheumatology, Janssen

Disclosure information not submitted.

Presentation(s):

• 1854: Nipocalimab’s Selective Targeting of FcRn and IgG Clearance Preserves Key Immune Functions

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time